Skip to main content
Clinical Trials/ACTRN12610000382077
ACTRN12610000382077
Completed
未知

In preterm infants born less than 33 weeks gestation will a tuna oil emulsion containing 121 mg/ml or 76 mg/ml of docosahexaenoic acid (DHA) compared with 37 mg/ml of DHA achieve an erythrocyte phospholipid fatty acid profile comparable to a term infant profile?

Women's and Children's Health Research Institute0 sites30 target enrollmentMay 12, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Preterm infants
Sponsor
Women's and Children's Health Research Institute
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 12, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Women's and Children's Health Research Institute

Eligibility Criteria

Inclusion Criteria

  • Infants born less than 33 weeks gestation after one but before five days of commencing any enteral feeds and with parental/guardian consent. Multiple births will be eligible and will be randomised individually. Women providing breast milk for their infant not taking DHA supplements or willing to stop taking supplements for duration study.

Exclusion Criteria

  • Infants with major congenital or chromosomal abnormalities. Infants likely to be transferred to remote locations where weekly blood tests can’t be done.

Outcomes

Primary Outcomes

Not specified

Similar Trials